nonresponse

1.Moreover presence of insulin resistance and diabetes are risk factors for fibrosis progression and nonresponse to antiviral therapy in chronic hepatitis C (CHC).

此外，胰岛抵抗和糖尿是慢性丙型肝炎（CHC）中纤维化进展以及对抗疗无应的危险。